150 related articles for article (PubMed ID: 24019232)
1. Identification of annexin II as a novel secretory biomarker for breast cancer.
Jeon YR; Kim SY; Lee EJ; Kim YN; Noh DY; Park SY; Moon A
Proteomics; 2013 Nov; 13(21):3145-56. PubMed ID: 24019232
[TBL] [Abstract][Full Text] [Related]
2. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
4. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
5. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
Kim MS; Lee EJ; Kim HR; Moon A
Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381
[TBL] [Abstract][Full Text] [Related]
6. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
7. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
[TBL] [Abstract][Full Text] [Related]
8. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.
Zhang J; Guo B; Zhang Y; Cao J; Chen T
Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413
[TBL] [Abstract][Full Text] [Related]
9. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
[TBL] [Abstract][Full Text] [Related]
10. H-Ras-specific upregulation of granulocyte colony-stimulating factor promotes human breast cell invasion via matrix metalloproteinase-2.
Park S; Kim ES; Noh DY; Hwang KT; Moon A
Cytokine; 2011 Jul; 55(1):126-33. PubMed ID: 21524920
[TBL] [Abstract][Full Text] [Related]
11. Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells.
Koh MS; Moon A
Biochem Biophys Res Commun; 2011 Mar; 406(1):25-9. PubMed ID: 21281602
[TBL] [Abstract][Full Text] [Related]
12. A novel role for flotillin-1 in H-Ras-regulated breast cancer aggressiveness.
Koh M; Yong HY; Kim ES; Son H; Jeon YR; Hwang JS; Kim MO; Cha Y; Choi WS; Noh DY; Lee KM; Kim KB; Lee JS; Kim HJ; Kim H; Kim HH; Kim EJ; Park SY; Kim HS; Moon WK; Choi Kim HR; Moon A
Int J Cancer; 2016 Mar; 138(5):1232-45. PubMed ID: 26413934
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.
Sharma M; Ownbey RT; Sharma MC
Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.
Song MN; Moon PG; Lee JE; Na M; Kang W; Chae YS; Park JY; Park H; Baek MC
Arch Pharm Res; 2012 Oct; 35(10):1839-47. PubMed ID: 23139137
[TBL] [Abstract][Full Text] [Related]
16. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma.
Mlynarek AM; Balys RL; Su J; Hier MP; Black MJ; Alaoui-Jamali MA
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):910-8. PubMed ID: 17875858
[TBL] [Abstract][Full Text] [Related]
17. Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.
Dowling P; Maurya P; Meleady P; Glynn SA; Dowd AJ; Henry M; Clynes M
Anticancer Res; 2007; 27(3A):1309-17. PubMed ID: 17593624
[TBL] [Abstract][Full Text] [Related]
18. Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target.
Zeidan B; Jackson TR; Larkin SE; Cutress RI; Coulton GR; Ashton-Key M; Murray N; Packham G; Gorgoulis V; Garbis SD; Townsend PA
Oncotarget; 2015 Aug; 6(25):21421-7. PubMed ID: 26093083
[TBL] [Abstract][Full Text] [Related]
19. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
20. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
Dai Z; Liu YK; Cui JF; Shen HL; Chen J; Sun RX; Zhang Y; Zhou XW; Yang PY; Tang ZY
Proteomics; 2006 Nov; 6(21):5857-67. PubMed ID: 17068759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]